The glucagon-like peptide-1 receptor agonist Exendin 4 has a protective role in ischemic injury of lean and steatotic liver by inhibiting cell death and stimulating lipolysis.
about
Contrast-Based Real-Time Assessment of Microcirculatory Changes in a Fatty Liver After Ischemia Reperfusion InjuryExendin-4 Improves Nonalcoholic Fatty Liver Disease by Regulating Glucose Transporter 4 Expression in ob/ob Mice.Effects of glucagon-like peptide-1 receptor agonists on non-alcoholic fatty liver disease and inflammationMitigation of autophagy ameliorates hepatocellular damage following ischemia-reperfusion injury in murine steatotic liver.A Novel Interacting Protein SERP1 Regulates the N-Linked Glycosylation and Function of GLP-1 Receptor in the Liver.GLP-1 receptor agonists: Nonglycemic clinical effects in weight loss and beyond.Circulating concentrations of GLP-1 are associated with coronary atherosclerosis in humans.Extrapancreatic effects of incretin hormones: evidence for weight-independent changes in morphological aspects and oxidative status in insulin-sensitive organs of the obese nondiabetic Zucker rat (ZFR).Review on the effect of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors for the treatment of non-alcoholic fatty liver disease.Loss of L-selectin-guided CD8+ , but not CD4+ , cells protects against ischemia reperfusion injury in a steatotic liver.Liraglutide reduces lipid accumulation in steatotic L‑02 cells by enhancing autophagy.Exendin-4 attenuates brain death-induced liver damage in the rat.Dropping in on lipid droplets: insights into cellular stress and cancer
P2860
Q30362299-282A3347-D0D2-4BE1-8682-E44FFE9DE556Q34097903-E5122F49-EB77-4D58-A846-23EFCB71C705Q34405101-380FDB5E-AC34-45AF-B6F1-F4A11E41A3B5Q34627493-CA74538C-F72B-42C0-AD91-8DE7F24EF44CQ36396618-531FAB8B-0B84-4CCA-9E71-40E4CE460F82Q36406821-E3164CFA-CA1E-40D3-9F58-0918EA959658Q37153223-7D739526-8DCE-408F-81D3-74513F17049CQ37176743-1511B207-CC6F-41F7-9975-9B58061C1034Q38527138-CE0F49BC-C056-4768-8834-E981D741F58EQ38764581-20691E29-EB7B-4E22-A7A1-4E1603253780Q38955646-5CFC2DD2-3E1E-4AF4-B882-07E7983CA456Q52150032-6255FCA6-3F43-4868-8E7A-BF633345310DQ57629429-8323D11B-69E6-420E-BF9F-9BE3E87F11FA
P2860
The glucagon-like peptide-1 receptor agonist Exendin 4 has a protective role in ischemic injury of lean and steatotic liver by inhibiting cell death and stimulating lipolysis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The glucagon-like peptide-1 re ...... ath and stimulating lipolysis.
@en
The glucagon-like peptide-1 re ...... ath and stimulating lipolysis.
@nl
type
label
The glucagon-like peptide-1 re ...... ath and stimulating lipolysis.
@en
The glucagon-like peptide-1 re ...... ath and stimulating lipolysis.
@nl
prefLabel
The glucagon-like peptide-1 re ...... ath and stimulating lipolysis.
@en
The glucagon-like peptide-1 re ...... ath and stimulating lipolysis.
@nl
P2093
P2860
P1476
The glucagon-like peptide-1 re ...... eath and stimulating lipolysis
@en
P2093
Allan Kirk
Carlos Abramowsky
Frank Anania
Nimita Fifadara
Nitika A Gupta
Rene Romero
Rong Jiang
Vasantha L Kolachala
P2860
P304
P356
10.1016/J.AJPATH.2012.07.015
P407
P50
P577
2012-09-05T00:00:00Z